Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Solidago Hevert Complex
- Development stage
- Unknown
- Lead developer
- Hevert-Arzneimittel
- Administration
- Oral
01
Overview
Solidago Hevert Complex is a homeopathic combination product developed by Hevert-Arzneimittel for the treatment of bladder and urinary tract infections, including cystitis and urethritis. It contains a mixture of homeopathically prepared active ingredients: *Solidago virgaurea* (European goldenrod), *Apis mellifica* (honeybee), *Atropa belladonna* (deadly nightshade), *Juniperus communis* (common juniper), *Lytta vesicatoria* (Cantharis/Spanish fly), and *Acidum nitricum* (nitric acid). The product is designed to stimulate diuresis, flush out pathogens, relieve spasmodic pain, and reduce inflammation in the urinary tract.
- Brand names
- Solidago Hevert Complex
- Other names
- Solidago Hevert Complex DropsSolidago Hevert Complex Tropfen
Beyond the preview
Go deeper on Solidago Hevert Complex.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Solidago Hevert Complex.